Skip to main content
Premium Trial:

Request an Annual Quote

David Roth, Pilar de la Huerta

Sygnis has appointed David Roth as its new CFO. In this role, Roth will be in charge of financial strategy and accounting processes. Former CFO Pilar de la Huerta will remain with the company, serving as co-CEO with Heikki Lanckriet and as chief business development officer. Roth comes to Sygnis with over 20 years of financial management experience focused on the healthcare sector, and has spent the last several years serving as CFO for several international organizations.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.